omniscope.aiCrawled Nov 6, 2026
The page offers early access to Omniscope’s sequencing platforms and discusses immune system monitoring.
The page describes osLifetime, a tool to track immune systems for healthspan optimization through monitoring and insights.
The page presents osLifetime, a tool to track immune systems for healthspan optimization through monitoring and insights.
The page explains how immune system decoding predicts patient responses and designs cellular therapies.
The page presents a case study on pediatric rhabdoid cancer treatment, authored by Holger Heyn, Vijay Vaswani, and Alexandra Avgustinova, published June 15, 2024.
The page lists recent publications involving Omniscope and describes its immune system analysis.
The Future of Human Performance.
Second Network event of RESPIRE-EXCEL Consortium co-hosted by Omniscope.
Omniscope's new osLifetime platform uses a cellular analysis of the immune system to help individuals track, understand, and improve their personal aging process.
Highly cited researchers identified from top 1% of publications cited per field and year in the Web of Science.
The company seeks employees to apply science for healthcare access globally.
The company recruits a Head of Operations for its Laboratory in Spain.
The company hires a Laboratory Technician for its Spain location.
Geoffrey develops initiatives combining sectoral needs, policy, technology, and future vision, with over 20 years of experience in business representation and organizational management.
Dr. Heyn leads the Single Cell Genomics Group at the Spanish National Centre for Genomic Analysis and has co-authored over 80 publications, securing over €7.5 million in funding.
Lynnette brings financial sector experience to Omniscope, including roles at Aberdeen Asset Management, and serves as People and Sustainability Officer.
The page promotes Omniscope’s immune system sequencing technology and invites contact for updates.
The page promotes immune system analysis for performance, healthspan, and therapy engineering.